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The frequency of chromosomal aberrations
(CAs) in human peripheral blood lympho-
cytes (PBLs) measured with the conventional
cytogenetic assay in metaphase cells has rou-
tinely been used for several decades as a tool
to monitor occupational and environmental
exposures to genotoxic carcinogens. There is
ample evidence of the value of this biomarker
for the identification of occupational and
environmental hazards (Albertini et al. 2000;
Bonassi et al. 2005; Carrano and Natarajan
1988; Rossner et al. 1995; S ˇrám and Binkova
2000; Waters et al. 1999). However, the con-
cept of chromosomal damage as a biomarker
of early carcinogenic effects rests on the evi-
dence of an association between biomarker
frequency and cancer risk, in addition to that
of an association between biomarker and
exposure to genotoxic agents.
The hypothesis of a positive association
between the frequency of CAs in PBLs and
the risk of cancer at different sites has been
supported—besides theoretical considerations
(Cheng and Loeb 1993; Mitelman 2000;
Sorsa et al. 1992; Yunis 1983)—by numerous
clinical observations, in particular, of patients
suffering from hereditary chromosome break-
age syndromes (Mathur et al. 2000) and seve-
ral other precancerous conditions such as
preleukemic states of adult T-cell leukemia
(Nishino 1988), dysplastic nevus syndrome
(Caporaso et al. 1987), or nevoid basal-cell
syndrome (Shafei-Benaissa et al. 1998). Case-
series and case–control studies have reported
a signiﬁcant increase in the frequency of aber-
rant cells in untreated cancer patients
(Abarbanel et al. 1991; Barrios et al. 1988,
1991; Dave et al. 1995; Dhillon and Dhillon
1998; Dhillon et al. 1996; Gebhart et al.
1993; Trivedi et al. 1998), but these studies
have been subject to criticism because of
small sample sizes and not accounting for the
inherent reverse causality bias, that is, when
the biomarker may be affected by the disease. 
More conclusive evidence on the associa-
tion between CA and cancer comes from
prospective cohort studies (Bonassi et al. 2004).
An increased risk of cancer incidence was
observed in individuals classiﬁed as having high
CA frequency in a Nordic cohort (Hagmar
et al. 1994, 1998), in an Italian cohort (Bonassi
et al. 1995), and, limited to chromosome-type
aberrations (CSAs) in a nested case–control
study carried out in Taiwan (Liou et al. 1999).
In a case–control study nested within the joint
Nordic and Italian cohorts, the association
between CA frequency and risk of cancer was
not modified by sex, age, cigarette smoking,
occupational exposure, or time since the cyto-
genetic assay (Bonassi et al. 2000).
In the Czech Republic, the evaluation of
CA frequency in PBLs has been included
since 1975 in regular medical checkups of
workers exposed to selected occupational haz-
ards, making it feasible to identify a cohort of
individuals for prospective follow-up for can-
cer in order to conﬁrm the results of the stud-
ies from Nordic countries, Italy, and Taiwan.
The large number of individuals with CA
measurements and the detailed cytogenetic
records allowed us to test the hypothesis that
speciﬁc cytogenetic end points may be linked
to the incidence of cancer at speciﬁc anatomi-
cal sites, thus expanding our preliminary
results, in particular, those concerning a group
of miners exposed to radon (Smerhovsky et al.
2001, 2002).
Materials and Methods
Study population. The study was approved by
the ethical committee of the National
Institute of Public Health (Prague) and con-
sisted of subjects examined in the period
between 7 May 1975 and 7 April 2000. An
overall number of 22,427 cytogenetic analyses
were obtained from 15 collaborating cytoge-
netic laboratories. We excluded 1,387 (6.2%)
results with either incomplete data on sub-
jects’ identification or based on fewer than
100 metaphases; we also excluded 257 assays
corresponding to 117 subjects with a diagno-
sis of cancer before the date of the ﬁrst assay.
Therefore, 11,991 subjects and 20,783 results
were available for analysis. Many of the sub-
jects included in the study were repeatedly
examined [3,305 subjects (27.6%) underwent
two or more analyses]. However, because sub-
jects in the highest CA level at first analysis
were more frequently reexamined, in all
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There is evidence that increased frequency of chromosomal aberration (CA) in peripheral blood
lymphocytes is a predictor of cancer, but further data are needed to better characterize CA as
marker of cancer risk. From the archives of 15 laboratories we gathered cytogenetic records of
11,834 subjects who were free of cancer at the moment of blood drawing and who underwent
cytogenetic examination for preventive purposes in the Czech Republic during 1975–2000. We
linked these records to the national cancer registry, revealing a total of 485 cancer cases. Subjects
were classified according to the percentiles of CA distribution within each laboratory as low
(0–33rd percentile), medium (34–66th percentile), and high (66–100th percentile). Subjects were
further classiﬁed by occupational exposure and by subclass of CA. We found a signiﬁcant associa-
tion between the overall cancer incidence and the presence of chromosome-type aberrations [rela-
tive risk (RR) for high vs. low CA level = 1.24; 95% conﬁdence interval (CI), 1.03–1.50] but not
chromatid-type aberrations. Stomach cancer showed a strong association with frequency of total
CA (RR = 7.79; 95% CI, 1.01–60.0). The predictivity of CA observed in subjects exposed to vari-
ous classes of carcinogens did not signiﬁcantly differ from the group of nonexposed subjects. This
study contributes to validation of CA as a predictive marker of cancer risk, in particular, of stomach
cancer; the association between CA frequency and cancer risk might be limited to chromosome-
type aberrations. Key words: cancer risk, chromosomal aberrations, cohort study, cytogenetic assay,
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Research Articlesubsequent analyses we used the result of the
ﬁrst cytogenetic assay for all subjects. Finally,
we restricted all of the analyses to subjects hav-
ing 100 metaphases evaluated to avoid those
subjects with ad hoc ascertainment often due
to unusual exposures, leaving 11,834 subjects
in the study, which contributed 113,967
person-years to the total follow-up time.
Most subjects (n = 9,776, 82.6%) under-
went cytogenetic testing because of occupa-
tional exposure to known or suspected
genotoxic agents. A smaller group (n = 1,913)
included subjects who were involved as con-
trols in biomonitoring studies. Subjects were
stratified into five groups according to most
important occupational exposures. For 1.2%
(n = 145) of the participants, we were not
able to establish the reason for the cytogenetic
analysis, and these subjects were added to the
group classiﬁed as “other exposures.”
Cytogenetic analysis. The cytogenetic
analysis was carried out in 15 cytogenetic
laboratories of the Czech Public Health
Service. All laboratories used the same proto-
col for the whole study period. We used the
conventional Hungerford method on short-
term cultures for 50 hr, with all cells being in
the first division. Peripheral blood was col-
lected by venopuncture into heparinized
tubes, and whole blood cultures were estab-
lished within 24 hr from the blood collection.
Tubes with heparinized blood were kept at
4–8°C until use. Cultures were set up in
RPMI 1640 medium supplemented with
20% calf serum and 1% phytohemagglutinin.
Two hours before harvesting, colchicin was
added. Cells were collected by centrifugation,
resuspended in a prewarmed hypotonic solu-
tion (0.075 M KCl) for 20 min, and ﬁxed in
acetic acid/methanol (1:3, vol/vol) on slides.
These were air dried and stained with 5%
Giemsa solution (pH 6.8). Slides from each
culture were numbered and blindly scored. At
least 100 well-spread metaphases with 46 ± 1
centromeres were examined (Bavorova et al.
1989; Rossner et al. 1998). Total CAs were
subclassified as CSAs (including chromo-
some-type breaks, ring chromosomes, marker
chromosomes, and dicentrics) and chromatid-
type aberrations (CTAs; including chromatid-
type breaks and chromatid exchanges)
(Hagmar et al. 2004). Gaps were not scored
as aberrations.
Cancer incidence and mortality. Infor-
mation on the incidence of cancer and cause-
specific mortality of members of the cohort
was obtained from the National Cancer
Registry for the period 1 May 1975 through
31 May 2001 (end of follow-up) and coded
according to the International Classiﬁcation of
Diseases, 9th Revision [ICD-9; World Health
Organization (WHO) 1975]. The link
between our records and the database of the
cancer registry was based on unique personal
identiﬁcation numbers. In the case of uncer-
tainty, we checked the relevant code in records
kept by employers. The overall number of
cancer cases was 485, including 32 cases of
carcinoma in situ. A total of 257 subjects were
excluded because of the onset of cancer before
the date of assay.
Statistical methods. To standardize for
interlaboratory variability, subjects were clas-
sified according to the percentiles of CA
distribution within each laboratory as low
(0–33rd percentile), medium (34–66th per-
centile), or high (67–100th percentile). Given
the low absolute frequency of CTAs and
CSAs, subjects were classified according to
presence or absence of these aberrations.
We used the Cox regression analysis (Cox
and Oakes 1990) to model the association
between cancer incidence and CA frequency.
All models included age at first test and sex;
time from the ﬁrst test was included as a time-
dependent variable. In addition, tobacco smok-
ing (yes/no/ex-smoker) and occupational
exposure (recoded in six classes) were included
as potential confounders. Routine diagnostic
tests did not detect any substantial violation of
underlying assumptions of the Cox regression.
We used SPSS for Windows (SPSS Inc.,
Chicago, IL, USA) and Stata statistical soft-
ware (Stata Corporation, College Station, TX,
USA) for all analyses. 
Results
The major descriptive characteristics of the
cohort are presented in Table 1, stratified
according to occupational exposure. Total CA
frequency, CTAs, and CSAs were signifi-
cantly higher (p < 0.001) in the group occu-
pationally exposed to ionizing radiation
compared with unexposed referents.
A small but not statistically significant
increase in relative risk (RR) was observed for
total cancer incidence in subjects with
medium and high levels of CAs when com-
pared with the low levels, whereas a signifi-
cant 24% increase in RR [95% confidence
interval (CI), 3–50%] was found in subjects
bearing one or more CSAs (Table 2).
In the analysis of speciﬁc cancer sites, we
found a signiﬁcant association between a high
level of CAs and cancer of digestive organs
(RR = 1.86; 95% CI, 1.05–3.28), particularly
for stomach cancer, with an RR of 7.79 (95%
CI, 1.01–60.03). A signiﬁcant increase in the
RR of cancers of other and unspecified sites
was found in subjects with CSAs. 
In the groups defined by occupational
exposure, we did not observe signiﬁcant asso-
ciations between CA frequency and RR of all
cancers (Table 3). The only significant find-
ing was the increased risk of all cancers
among workers exposed to polyclic aromatic
hydrocarbons with CSAs (RR = 1.56; 95%
CI, 1.01–2.41).
The cross-tabulation of occupational expo-
sures with selected cancer sites produced sig-
niﬁcant ﬁndings only for cancers of digestive
organs. The small number of cases limited this
analysis, although a stronger association
between chromosomal damage and cancers of
digestive organs was evident among workers
exposed to ionizing radiation, where no cases
were found in the lowest CA frequency group,
whereas three and nine were found in the
medium and high groups, respectively. This
skewed distribution of cases made it impossi-
ble to estimate RRs, but the test of linear
trend was highly signiﬁcant (p < 0.01). 
In order to evaluate if the inclusion of
tumors in situ (n = 32) or nonmelanoma skin
cancers (n = 70) may have affected the associ-
ation between cancer risk and chromosome
damage because of detection bias, we fitted
models with and without these cases. The
model without these cases showed a little
stronger association that was still not signiﬁ-
cant (RRmedium = 1.27; 95% CI, 0.97–1.67;
RRhigh = 1.22; 95% CI, 0.93–1.59). 
Discussion
The role of some chemicals and ionizing radi-
ation in inducing DNA double-strand breaks
that, if not repaired, are transformed into CAs
during cell division is well established (Bryant
1998; Natarajan 1993; Obe et al. 2002;
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Table 1. Distribution of subjects in the cohort by age at ﬁrst test, sex, duration of follow-up, cancer frequency, and frequency of CAs.
No. of Mean age at Sex Mean years Cancer Median (25th–75th percentiles)
Occupational exposure subjects ﬁrst test (years) (% males) since test cases (%) CAs CTAs CSAs
Ionizing radiation 676 40.3 70.4 11.6 57 (8.4) 2.5 (1.5–4.0) 2.0 (1.0–3.0) 1.0 (0.0–2.0)
Cytostatic drugs 2,150 36.5 12.8 7.4 61 (2.8) 2.0 (1.0–3.0) 1.3 (1.0–2.0) 0.0 (0.0–1.0)
Polyclic aromatic hydrocarbons 2,241 39.4 86.1 10.1 108 (4.8) 2.0 (1.0–3.5) 1.5 (1.0–2.4) 1.0 (0.0–1.0)
Aromatic amines 851 40.3 57.8 9.0 28 (3.3) 2.0 (1.3–3.0) 1.8 (1.0–3.0) 0.6 (0.0–1.0)
Other exposures 4,031 38.0 58.7 10.7 170 (4.2) 2.0 (1.0–3.0) 1.0 (1.0–2.0) 0.5 (0.0–1.0)
Nonexposed 1,913 36.2 55.2 8.8 61 (3.2) 2.0 (1.0–3.0) 1.0 (0.5–2.0) 0.0 (0.0–1.0)
Total cohort 11,862 38.0 55.6 9.6 485 (4.1) 2.0 (1.0–3.0) 1.0 (1.0–2.0) 0.5 (0.0–1.0)Palitti 1998; Savage 1998). Measuring the
frequency of chromosomal damage in
humans exposed to occupational and environ-
mental clastogens has been a priority in pub-
lic health studies for decades, and an
increased level of CAs in population groups is
currently interpreted as evidence of genotoxic
exposure and early biologic effects on DNA
(Albertini et al. 2000; S ˇrám 1981; S ˇrám et al.
1983; Waters et al. 1999). However, before
using CAs as a marker of cancer risk, it is
essential to establish not only the presence of
an association with exposure but also the link
with cancer occurrence (WHO 2001).
The results from this study contribute
important evidence on CAs as a predictive can-
cer biomarker. One strength of these ﬁndings
is the homogeneity of cytogenetic protocols in
the laboratories included in the study, which
should have reduced the misclassiﬁcation due
to technical variability. Furthermore, the size
of this cohort, which is more than double the
size of the combined Nordic–Italian cohorts
(Hagmar et al. 1998), allows the analysis of
specific cancer sites, the study of interaction
with occupational exposures, and the evalua-
tion of subclasses of CAs.
The association between the total fre-
quency of CAs and all cancer incidence was
quantitatively lower than that reported in pre-
vious studies (Hagmar et al. 1998, 2004), at
least regarding the risk for those subjects in
the highest tertile of the distribution of CA
frequency. A possible explanation of this ﬁnd-
ing is the implementation of preventive inter-
ventions after the detection of a subject with a
high CA level. In the Czech Republic, CA
surveying was part of a systematic effort to
provide an early detection of occupational
damages, and subjects with a CA frequency of
≥ 4% were included in a program that was
intended to reduce the risks for these individ-
uals. An alternative explanation is that the
association between CA frequency and cancer
risk is weaker than previously considered.
Our results on the predictivity of CA sub-
classes support early data from Taiwan (Liou
et al. 1999) because a significant increase of
incidence is described only for CSAs and not
for CTAs. These findings are in agreement
with the evidence that a double-strand break—
which is a consolidated early event of carcino-
genesis—is the primary lesion for CSAs, and
that agents that produce double-strand breaks,
such as ionizing radiation and radiomimetic
clastogenic chemicals, create CSAs (Pfeiffer
et al. 2000). Such a difference was not detected
in the combined analysis of the Nordic and
Italian cohorts (Hagmar et al. 2004).
The association between CA frequency
and risk of specific cancers did not reveal a
great variability, and positive associations
might have been generated by multiple com-
parisons; however, the increase in cancers of
digestive organs, and most notably stomach
cancer, is a potentially important observation-
that requires conﬁrmation.
The presence of interaction between
exposure to carcinogens and the predictivity
of CAs has been another issue largely debated
in the literature. The presence of a stronger
association between CA frequency and risk of
cancer in radon-exposed workers than in
other workers or controls, which has been
already reported (Smerhovsky et al. 2002), is
not consistent with the findings of the
Nordic and Italian cohorts, in which the
association between increased CA frequency
and cancer risk appeared to be independent
from exposure to carcinogens or smoking
habit (Bonassi et al. 2000). The findings
from the present study were not conclusive in
this direction because the predictivity of CA
frequency observed in subjects exposed to
various classes of carcinogens did not signiﬁ-
cantly differ from the group of nonexposed
subjects. However, when the group of diges-
tive cancers was cross-tabulated by occupa-
tional exposure, a significant association was
seen only in the group of workers exposed to
ionizing radiation. To better disentangle the
interaction between radiation, CAs, and can-
cer, we further broke down CA subclasses in
chromosome breaks and exchanges, and inter-
estingly, the events mostly associated with
digestive cancer incidence were exchanges,
Article | Chromosomal aberrations and risk of cancer
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Table 2. Results from the multivariate Cox regression analysis of CA frequency (total and by subclass) and cancer incidence.
Incident cases Total CAsa
(by tertile of CA distribution) (by tertile of CA distribution) RR≥ 1 (95% CI)
Cancer site ICD-9 code Low Medium High RRmedium (95% CI) RRhigh (95% CI) CTASb (≥ 1 vs. 0) CSAsb (≥ 1 vs. 0)
Lip, oral cavity, and pharynx 140–149 4 1 9 0.23 (0.03–2.06) 1.89 (0.55–6.50) 1.61 (0.36–7.33) 1.98 (0.61–6.42)
Digestive organs 150–159 16 31 48 1.47 (0.80–2.70) 1.86 (1.05–3.28) 1.20 (0.69–2.09) 1.46 (0.94–2.27)
Stomach 151 1 3 12 2.25 (0.23–21.66) 7.79 (1.01–60.03) 1.43 (0.32–6.30) 2.79 (0.79–9.83)
Colon, rectum 153–154 13 24 22 1.41 (0.72–2.79) 0.94 (0.47–1.89) 1.12 (0.56–2.22) 1.16 (0.68–1.99)
Respiratory and intrathoracic organs 160–165 19 22 38 0.87 (0.47–1.61) 1.02 (0.58–1.80) 0.86 (0.49–1.50) 1.26 (0.78–2.03)
Trachea, bronchus, and lung 162 18 21 34 0.87 (0.46–1.64) 0.96 (0.54–1.74) 0.84 (0.48–1.50) 1.27 (0.77–2.10)
Bone, connective tissue, skin, and breast 170–175 31 51 46 1.29 (0.82–2.01) 1.08 (0.68–1.73) 1.19 (0.75–1.90) 0.88 (0.62–1.26)
Skin (nonmelanoma) 173 20 25 25 0.97 (0.54–1.75) 0.89 (0.49–1.63) 1.01 (0.56–1.83) 0.81 (0.50–1.30)
Breast 174 9 19 11 1.60 (0.72–3.55) 0.97 (0.40–2.36) 0.97 (0.44–2.13) 1.05 (0.54–2.05)
Genitourinary organs 179–189 33 45 40 1.05 (0.67–1.66) 0.82 (0.51–1.32) 0.93 (0.59–1.46) 1.17 (0.80–1.71)
Uterus 179–182 15 19 16 1.02 (0.52–2.01) 0.94 (0.46–1.92) 0.89 (0.45–1.74) 1.32 (0.74–2.34)
Prostate 185 3 2 7 0.49 (0.08–3.10) 1.23 (0.29–5.28) 0.81 (0.21–3.16) 0.70 (0.20–2.41)
Bladder 188 6 3 4 0.38 (0.09–1.53) 0.34 (0.09–1.27) 0.78 (0.21–2.88) 0.70 (0.23–2.11)
Other and unspeciﬁed sites 190–199 5 12 8 1.94 (0.68–5.54) 1.17 (0.38–3.64) 0.99 (0.37–2.68) 3.91 (1.33–11.54)
Lymphatic and hematopoietic tissue 200–208 5 11 10 1.70 (0.59–4.91) 1.49 (0.50–4.44) 0.66 (0.28–1.58) 1.73 (0.75–4.04)
Total cancers 140–208 113 173 199 1.17 (0.92–1.48) 1.13 (0.89–1.43) 1.02 (0.81–1.28) 1.24 (1.03–1.50)*
aReference level: lowest tertile of CA distribution. bReference level: subjects with “0” CTAs or CSAs. *p < 0.05. 
Table 3. Results from the multivariate Cox regression analysis of CA frequency (total and by subclass) and total cancer incidence by occupational exposure.
No. of Total CAsa (by tertile of CA distribution) RR≥ 1 (95% CI)
Occupational exposure subjects RRmedium (95% CI) RRhigh (95% CI) CTAsb (≥ 1 vs. 0) CSAsb (≥ 1 vs. 0)
Ionizing radiation 676 1.42 (0.61–3.33) 1.39 (0.61–3.16) 1.35 (0.62–2.89) 1.17 (0.65–2.10)
Cytostatic drugs 2,150 1.09 (0.57–2.07) 0.96 (0.50–1.85) 0.95 (0.50–1.79) 1.33 (0.79–2.25)
Polyclic aromatic hydrocarbons 2,241 1.27 (0.73–2.25) 1.39 (0.82–2.34) 1.20 (0.70–2.04) 1.56 (1.01–2.41)
Aromatic amines 851 1.85 (0.59–5.80) 1.29 (0.41–4.07) 1.06 (0.31–3.61) 0.84 (0.40–1.78)
Other exposures 4,031 1.04 (0.71–1.53) 0.86 (0.58–1.26) 0.83 (0.57–1.29) 1.17 (0.85–1.61)
Nonexposed 1,913 1.23 (0.68–2.22) 1.55 (0.80–3.01) 1.13 (0.63–2.03) 1.33 (0.80–2.21)
Total 11,862 1.17 (0.92–1.48) 1.13 (0.88–1.43) 1.02 (0.81–1.28) 1.24 (1.03–1.50)*
aReference level: lowest tertile of CA distribution. bReference level: subjects with “0” CTAs or CSAs. *p < 0.05. both chromatid exchanges (p < 0.01) and
chromosome exchanges (p < 0.05).
In conclusion, this study confirms previ-
ous reports of an association between the
extent of chromosomal damage and the risk of
cancer. In contrast to most previous reports,
this association appeared to be limited to the
presence of CSAs, and the magnitude of the
excess risk might be lower than previously
described. An original result of this analysis
concerns the presence of a stronger association
between CA frequency and cancers of the
digestive tract. Also, the higher risks found in
the group exposed to ionizing radiation is a
peculiar ﬁnding of this cohort and deserves a
deeper insight.
Furthermore, the possibility that the
implementation of occupational preventive
programs focused on workers with high CA
frequency might have modified their risk of
cancer is a plausible explanation of these
results, and it will be further evaluated with
ad hoc studies, reconstructing occupational
lives of subjects with the highest frequency of
CA at their ﬁrst cytogenetic analysis.
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